Demonstrates significant antibacterial activity of silver nanoparticles in bacteria, indicating potential for sustainable antimicrobials.
Introduction: Nanomaterial-based antimicrobial agents have gained global attention due to their potent antibacterial activity. Green synthesis using plant extracts offers an eco-friendly and cost-effective alternative to conventional methods. In this study, silver nanoparticles (Ag NPs) were synthesised using Cannabis sativa and Aegle marmelos leaf extracts, and their antimicrobial efficacy was evaluated. Methods: Ag NPs were synthesised using a domestic microwave (180 sec, 400 W) with plant extracts. The synthesised NPs were characterised by X-ray diffraction (XRD), UV-visible spectroscopy, scanning electron microscopy (SEM), and energy-dispersive X-ray spectroscopy (EDS). Antibacterial activity was tested against Gram-positive (S. aureus) and Gram-negative (E. coli, S. typhi, Pseudomonas) bacteria at different concentrations. Results: Characterisation confirmed spherical Ag NPs clustered in morphology. Ag NPs synthesised using Cannabis sativa showed maximum inhibition zones of ~14 ± 0.7 mm (Pseudomonas). Aegle marmelos-derived Ag NPs exhibited higher inhibition zones of ~24 ± 1.2 mm (Pseudomonas), surpassing those of the commercial antibiotic (ZID~12 ± 0.6 mm) after 24 h of incubation. Discussion: Green synthesis of Ag NPs using Cannabis sativa and Aegle marmelos extract proved effective and eco-friendly. Aegle marmelos-derived Ag NPs showed stronger antibacterial activity, likely due to richer phytochemicals. The NPs were particularly effective against Pseudomonas. These results highlight their potential as sustainable antimicrobial agents. Conclusion: Cannabis sativa and Aegle marmelos are effective plant sources for green synthesis of Ag NPs, which exhibit significant antibacterial activity for both Gram-positive and Gram-negative bacterial strains. In particular, they are most effective against Pseudomonas, highlighting their potential in targeting pathogenic microorganisms.
No takes yet. Share an insight, caveat, or question.
Kala et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: